Press release
Lung Cancer Surgery Market is Expected To Be Worth US$ 30 Billion Globally By 2022
The Lung Cancer Surgery Market is segmented on the lines of its procedures type, device type and regional. Based on procedures type segmentation it covers thoracotomy, lobectomy, sleeve resection, segmentectomy, pneumonectomy, minimally invasive surgeries. Based on device type segmentation it covers surgical instruments, hand instruments, powered surgical equipment, monitoring and visualizing systems, end surgical equipment. The Lung Cancer Surgery Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.The Lung Cancer Surgery Market is expected to exceed more than US$ 29.99 Billion by 2022 at a CAGR of 6.8% in the given forecast period.
You Can Browse Full Report: https://www.marketresearchengine.com/lung-cancer-surgery-market
This report provides:
1) An overview of the global market for Lung Cancer Surgery Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Lung Cancer Surgery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Lung Cancer Surgery Market are as follows:
• Growing Technological Advancement in lung cancer treatments
• Rising Geriatric Population
• Growing Incidence and Popularity of Lung Cancer
• Early stage detection and intervention Awareness about the disease
The restraining factors of Lung Cancer Surgery Market are as follows:
• Costliest lung cancer surgeries
Request Sample Report: https://www.marketresearchengine.com/lung-cancer-surgery-market
The scope of the report includes a detailed study of global and regional markets onLung Cancer Surgery Market with the reasons given for variations in the growth of the industry in certain regions.
Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Lung Cancer Surgical Devices Market, By Type
6.1 Introduction
6.2 Surgical Instruments
6.2.1 Hand Instruments
6.2.1.1 Staplers
6.2.1.2 Forceps
6.2.1.3 Retractors
6.2.1.4 RIB Shears
6.2.1.5 Trocars
6.2.1.6 Cutters
6.2.1.7 Clamps
6.2.1.8 Scissors
6.2.1.9 Elevators
6.2.1.10 Other Hand Instruments
7 Lung Cancer Surgical Procedures Market, By Type
8 Lung Cancer Surgery Market, By Region
9 Lung Cancer Surgical Devices Market , Competitive Landscape
10 Company Profiles
10.1 Introduction
10.2 Accuray Incorporated
10.3 Angiodynamics Inc.
10.4 Ethicon Us, LLC (Johnson & Johnson)
10.5 Intuitive Surgical Inc.
10.6 Olympus Corporation
10.7 Teleflex Incorporated
10.8 Ackermann Instrumente GmbH
10.9 Karl Storz GmbH
10.10 Scanlan International, Inc.
10.11 Trokamed GmbH
About Us
Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Surgery Market is Expected To Be Worth US$ 30 Billion Globally By 2022 here
News-ID: 784096 • Views: …
More Releases from (MRE) Report

Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018:
Weight Management Market 2018
The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…

Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018:
Home Healthcare Market 2018
The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…

Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018:
Healthcare 3D Printing Market 2018
The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS…

Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018:
Tumor Ablation Market 2018
The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…